RAD
RADIOPHARM THERANOSTICS LIMITED
$0.0070
▼ -12.50%
Market cap
$30M
Turnover
$30,951
Last price
$0.0070
Day change
-12.50%
Announcements
12
Range, past year
Open 0.029 · Low 0.006 · Now 0.007 · High 0.040
Open RAD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
RAD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
28/100
Wyckoff phase
Accumulation24d
Trend stage
Neutral
1 Day
-12.5%
1 Week
+0.0%
1 Month
-22.2%
1 Year
-75.9%
RSI
40
Avg daily range
16.8%
RADIOPHARM THERANOSTICS LIMITED scores 28 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 24 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
What stands out
- Trend R² 0.91 — highly linear uptrend
Points to watch
- 60d drawdown -65.0%
- High volatility (ATR 16.8%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
RAD announcements
Recent price-sensitive releases.
- 2026-08-28 Appendix 4E and Preliminary Final Report Preliminary Final Report
- 2026-08-26 RAD Doses First Patient in Second Cohort of BetaBart (RV-01) Progress Report
- 2026-08-20 RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial Progress Report
- 2026-08-17 RAD to meet with US FDA to align on RAD 101 Phase 3 Trial Progress Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-24 Reinstatement to Quotation Reinstatement to Official Quotation
- 2026-07-24 RAD completes A$12.5 M placement and launches A$6 M SPP Placement | Issued Capital - Other | Security Purchase Plan
More Health Care stocks
Most traded in the same sector.